ARS Pharmaceuticals Announces Co-Promotion Agreement With Partner and Global Allergy Leader Alk-AbellÓ a/S to Expand Reach of Neffy® (Epinephrine Nasal Spray) to Additional U.S. Pediatricians

THOMSON REUTERS
02 May

ARS Pharmaceuticals Announces Co-Promotion Agreement With Partner and Global Allergy Leader Alk-AbellÓ a/S to Expand Reach of Neffy® (Epinephrine Nasal Spray) to Additional U.S. Pediatricians

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10